A randomized trial among women with heavy menstruation - Impact of a decision aid on treatment outcomes and costs

Health Expectations

Volumn 7, Issue 4, 2004, Pages 327-337

  Vuorma, Sirkku ^a   Teperi, Juha ^a   Aalto, Anna Mari ^a   Hurskainen, Ritva ^a,b   Kujansuu, Erkki ^c   Rissanen, Pekka ^d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Cost analysis; Decision aid; Menorrhagia; Psychological well being; Quality of life; Randomized trial

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH EDUCATION; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MENORRHAGIA; MENSTRUATION DISORDER; MULTICENTER STUDY; PATIENT EDUCATION; PATIENT SATISFACTION; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SOCIAL PSYCHOLOGY; TREATMENT PLANNING; WELLBEING;

ADULT; DECISION MAKING; FEMALE; FINLAND; HEALTH CARE COSTS; HUMANS; MENORRHAGIA; MIDDLE AGED; PAMPHLETS; PATIENT EDUCATION; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC;

EID: 9644274209     PISSN: 13696513     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1369-7625.2004.00297.x     Document Type: Article

References (19)

1. Molenaar S, Sprangers MAG, Postma-Schuit FCE, Rutgers EJT, Noorlander J, Hendriks J. et al. Feasibility and effects of decision aids. Medical Decision Making, 2000; 20: 112-127.
2. O'Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions (Cochrane review). Cochrane Database of Systematic Reviews, 2003; 2: CD001431.
3. Kennedy ADM, Sculpher MJ, Coulter A et al. Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs. JAMA, 2002; 288: 2701-2708.
4. Murray E, Davis H, Tai SS, Coulter A, Gray A, Haines A. Randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care. British Medical Journal, 2001; 323: 490-493.
5. Murray E, Davis H, Tai SS, Coulter A, Gray A, Haines A. Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care. British Medical Journal, 2001; 323: 493-496.
6. Vuorma S, Teperi J, Aalto A-M, Hurskainen R, Kujansuu E, Rissanen P. Impact of patient information booklet on treatment decision - a randomized trial among women with heavy menstruation. Health Expectation, 2003; 6: 290-297.
7. Luukkainen T, Lähteenmäki P, Toivonen J. Levonorgestrel- releasing intrauterine device. Annals of Medicine, 1990; 22: 85-90.
8. Schölten PC. Levonorgestrel IUD. Clinical Performance and Impact on Menstruation. Utrecht, the Netherlands: University of Utrecht, 1989.
9. Effective Health Care. The management of menorrhagia. Effective Health Care, 1995; Bulletin No. 9.
10. Aalto A-M, Aro AR, Teperi J. RAND-36 terveyteen liittyvän elämänlaadun mittarina [in Finnish: RAND-36 as a measure of Health-Related Quality of Life]. Saarijärvi: STAKES, 1999.
11. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item Health Survey 1.0. Health Economics, 1993; 2: 217-227.
12. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1980.
13. METELI. Occupational status, working environment, and morbidity among employees of metal industry factories [in Finnish: Ammattiasema, työolot ja sairastavuus metalliteollisuuden henkilöstöryhmissä]. Jyväskylä: Gummerus, 1977.
14. Wiklund I, Karlberg J, Lindgren R, Sandin K, Mattsson L. A Swedish version of the Women's Health Questionnaire. A measure of postmenopausal complaints. Acta Obstetricia et Gynecologica Scandinavica, 1993; 72: 648-655.
15. Vuorma S, Teperi J, Hurskainen R, Aalto A-M, Rissanen P, Kujansuu E. Correlates of women's preferences for treatment of heavy menstrual bleeding. Patient Education and Counseling, 2003; 92: 125-132.
16. Heikkinen K, Hujanen T, Rusama H. Guidelines for Health Care Unit Costs in Finland in 2000 [in Finnish: Terveydenhuollon yksikkökustannukset Suomessa vuonna 2000]. Helsinki: STAKES, 2001, 72 pp.
17. Fairclough DL, Cella DF. Functional assessment of cancer therapy (FACT-G): non-response rate to individual questions. Quality of Life Research, 1996; 5: 321-329.
18. Hurskainen R, Teperi J, Rissanen P, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet, 2001; 357: 273-277.
19. Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding (Cochrane review). Cochrane Database of Systematic Reviews, 2003; CD000329.